DOJ secures $305 million in penalties to resolve generics case

The Department of Justice has agreed to defer its price-fixing prosecution of Teva Pharmaceuticals after the generic drugmaker agreed to pay the largest domestic cartel fine in US history and divest a cholesterol medication.

Unlock unlimited access to all Global Competition Review content